Zecon Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
- Paid Up Capital ₹ 1.30 M
- Company Age 16 Year, 16 Days
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.50 M
- Revenue Growth 4.33%
- Profit Growth -2.91%
- Ebitda 56.12%
- Net Worth 24.87%
- Total Assets 16.71%
About Zecon Pharmaceuticals
Zecon Pharmaceuticals Private Limited (ZPPL) is a Private Limited Indian Non-Government Company incorporated in India on 04 February 2009 and has a history of 16 years. Its registered office is in Lucknow, Uttar Pradesh, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 1.30 M.
The company currently has active open charges totaling ₹1.50 M.
Rajeev Dhondiyal, Devraj Kishor, and Amit Rai serve as directors at the Company.
Company Details
- Location
Lucknow, Uttar Pradesh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U93000UP2009PTC036720
- Company No.
036720
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 Feb 2009
- Date of AGM
15 Jan 2024
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Who are the key members and board of directors at Zecon Pharmaceuticals?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Amit Rai  | Director | 04-Feb-2009 | Current |
| Rajeev Dhondiyal | Director | 04-Feb-2009 | Current |
| Devraj Kishor | Director | 04-Feb-2009 | Current |
Financial Performance of Zecon Pharmaceuticals.
Zecon Pharmaceuticals Private Limited, for the financial year ended 2020, experienced modest growth in revenue, with a 4.33% increase. The company also saw a slight decrease in profitability, with a 2.91% decrease in profit. The company's net worth Soared by an impressive increase of 24.87%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Zecon Pharmaceuticals?
In 2018, Zecon Pharmaceuticals had a promoter holding of 62.62% and a public holding of 37.38%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Raghunandan Manju Pharmaceuticals Private LimitedDevraj Kishor is a mutual person
Charges (Loans)
₹1.50 M
₹0
Charges Breakdown by Lending Institutions
- Union Bank Of India : 0.15 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 02 Jun 2014 | Union Bank Of India | ₹0.50 M | Open |
| 02 Jun 2014 | Union Bank Of India | ₹0.50 M | Open |
| 02 Jun 2014 | Union Bank Of India | ₹0.50 M | Open |
How Many Employees Work at Zecon Pharmaceuticals?
Unlock and access historical data on people associated with Zecon Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Zecon Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Zecon Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
